Cargando…
Mistaken administration of a repeat loading dose of Degarelix leading to acute psychosis
Advanced and metastatic prostate cancer is often managed with hormonal blockage. Luteinising hormone-releasing hormone antagonists achieve rapid testosterone suppression and are used for the treatment of advanced or metastatic prostate cancer. Degarelix is a luteinising hormone-releasing hormone ant...
Autores principales: | Hamdoon, Musaab, Satchi, Maria, Fawke, Fay, Madaan, Sanjeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897814/ https://www.ncbi.nlm.nih.gov/pubmed/33680481 http://dx.doi.org/10.1177/2054270420983105 |
Ejemplares similares
-
Nurse‐led one stop hematuria clinic: Outcomes from 2,714 patients
por: Madaan, Anika, et al.
Publicado: (2021) -
Urological Implications Associated with the Use of Recreational Drugs: A Narrative Review
por: Wani, Mudassir, et al.
Publicado: (2022) -
Evaluation of degarelix in the management of prostate cancer
por: Van Poppel, Hendrik
Publicado: (2010) -
Acute Generalized Cutaneous Lupus Erythematosus Repeatedly Mistaken for Cellulitis
por: Fischer, Nicole, et al.
Publicado: (2020) -
Degarelix and its therapeutic potential in the treatment of prostate cancer
por: Doehn, Christian, et al.
Publicado: (2009)